{'output': [['Sanofi', 'COMP', 'Obtain', 'Right', 'ORG/REG'], ['Sanofi', 'COMP', 'Develop', 'Fitusiran', 'PRODUCT'], ['Sanofi', 'COMP', 'Sell', 'Fitusiran', 'PRODUCT'], ['Sanofi Genzyme', 'COMP', 'Global Commercialization', 'Fitusiran', 'PRODUCT'], ['Alnylam Pharmaceuticals', 'COMP', 'Royalties', 'Fitusiran', 'PRODUCT'], ['Sanofi Genzyme', 'COMP', 'Rare Hematology Portfolio', 'Fitusiran', 'PRODUCT'], ['Alnylam', 'COMP', 'Global Development', 'New Treatment', 'PRODUCT'], ['Alnylam', 'COMP', 'Global Commercialization', 'New Treatment', 'PRODUCT'], ['Sanofi Genzyme', 'COMP', 'Sustained Interest', 'Alnylamâ€™s Portfolio', 'PRODUCT'], ['Sanofi', 'COMP', 'Opt', 'Other Alnylam Rare Genetic Disease Programs', 'PRODUCT'], ['Sanofi', 'COMP', 'Global License', 'One Right', 'CONCEPT'], ['Sanofi', 'COMP', 'Reporting', 'Geert De Clercq', 'PERSON'], ['Sanofi', 'COMP', 'Editing', 'Biju Dwarakanath', 'PERSON']]}